SRP54 - signal recognition particle 54 Gene
Also Known as SCN8
Species: Homo sapiens
About SRP54
This gene has 23 transcripts (splice variants), 217 orthologues, 1 paralogue and is associated with 5 phenotypes. Ubiquitous expression in testis (RPKM 26.2), thyroid (RPKM 18.4) and 25 other tissues.
Summary
Enables several functions, including 7S RNA binding activity; endoplasmic reticulum signal peptide binding activity; and guanyl ribonucleotide binding activity. Contributes to GTPase activity. Involved in granulocyte differentiation and protein targeting to ER. Located in cytosol and nucleus. Part of signal recognition particle, endoplasmic reticulum targeting. Implicated in severe congenital neutropenia 8. [provided by Alliance of Genome Resources, Apr 2022]
SRP54 Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001146282.2 | NP_001139754.1 | signal recognition particle 54 kDa protein isoform 2 |
| NM_001411017.1 | NP_001397946.1 | signal recognition particle 54 kDa protein isoform 3 |
| NM_003136.4 | NP_003127.1 | signal recognition particle 54 kDa protein isoform 1 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables 7S RNA binding |
IDA
IDA: Inferred from direct assay
|
9511762 | GOA |
| enables GDP binding |
IDA
IDA: Inferred from direct assay
|
8622769 | GOA |
| enables GTP binding |
IDA
IDA: Inferred from direct assay
|
8622769 | GOA |
| contributes to GTPase activity |
IDA
IDA: Inferred from direct assay
|
8247130 | GOA |
| enables GTPase activity |
IMP
IMP: Inferred from mutant phenotype
|
28972538 | GOA |
| enables endoplasmic reticulum signal peptide binding |
IDA
IDA: Inferred from direct assay
|
9511762 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
24965446 | GOA |
| enables ribonucleoprotein complex binding |
IDA
IDA: Inferred from direct assay
|
9511762 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in granulocyte differentiation |
IMP
IMP: Inferred from mutant phenotype
|
28972538 | GOA |
| involved in protein targeting to ER |
IMP
IMP: Inferred from mutant phenotype
|
18089836 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in cytoplasm |
IDA
IDA: Inferred from direct assay
|
10618370 | GOA |
| NOT located in nucleolus |
IDA
IDA: Inferred from direct assay
|
10618370 | GOA |
| located in nucleus |
IDA
IDA: Inferred from direct assay
|
18089836 | GOA |
| part of signal recognition particle, endoplasmic reticulum targeting |
IDA
IDA: Inferred from direct assay
|
18089836 | GOA |
SRP54 Protein Structure
SRP54_N: SRP54-type protein, helical bundle domain (6 - 83)
SRP54: SRP54-type protein, GTPase domain (101 - 296)
SRP_SPB: Signal peptide binding domain (326 - 431)
- 0
- 100
- 200
- 300
- 400
- 504 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
signal recognition particle 54 kDa protein |
|
Recombinant SRP54 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P74537 | SRP54 Protein, Human (sf9, His) | P61011 (M1-M504) | ≥ 95%, as determined by reducing SDS-PAGE. |
SRP54 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P82392 | SRP54 Antibody (YA2137) | WB, IHC-P, IP, FC | Mouse, Rat, Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Neutropenia, Severe Congenital, 8, Autosomal Dominant |
|
|
| Shwachman-Diamond Syndrome 1 |
|
|
| Autosomal Dominant Severe Congenital Neutropenia |
|
|
| Severe Congenital Neutropenia 8 |
|
|
| Severe Congenital Neutropenia |
|
|
| Neutropenia |
|
|
| Severe Congenital Neutropenia 7 |
|
|
| Spondylometaphyseal Dysplasia, Corner Fracture Type |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Canis familiaris | SRP54 | VGNC | VGNC:46807 |
| Bos taurus | SRP54 | VGNC | VGNC:35285 |
| Macaca mulatta | SRP54 | VGNC | VGNC:82247 |
| Felis catus | SRP54 | VGNC | VGNC:65683 |
| Rattus norvegicus | SRP54 | RGD | RGD:621390 |
| Others | SRP54 | NCBI |